Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/6412
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BUYSE, Marc | - |
dc.contributor.author | Poplavsky, J.L. | - |
dc.date.accessioned | 2007-12-20T16:07:42Z | - |
dc.date.available | 2007-12-20T16:07:42Z | - |
dc.date.issued | 1995 | - |
dc.identifier.citation | Blood coagulation and fibrinolysis, 6. p. S86-S92 | - |
dc.identifier.uri | http://hdl.handle.net/1942/6412 | - |
dc.language.iso | en | - |
dc.publisher | Lippincott Williams & Wilkins | - |
dc.title | Clinical evaluation of virus safety and inhibitor incidence: statistical considerations | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | S92 | - |
dc.identifier.spage | S86 | - |
dc.identifier.volume | 6 | - |
dc.bibliographicCitation.oldjcat | - | |
item.contributor | BUYSE, Marc | - |
item.contributor | Poplavsky, J.L. | - |
item.fulltext | No Fulltext | - |
item.fullcitation | BUYSE, Marc & Poplavsky, J.L. (1995) Clinical evaluation of virus safety and inhibitor incidence: statistical considerations. In: Blood coagulation and fibrinolysis, 6. p. S86-S92. | - |
item.accessRights | Closed Access | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.